Skip to content
Open access

339. Brexpiprazole for emerging psychosis in an adolescent female with Asperger-type autism: a single-case clinical evaluation

Sep 2026 · International Journal of Neuropsychopharmacology · Vol 29, pp. i139 - i139 · 0 citations

TL;DR

Bxpiprazole appears to be effective and well-tolerated in managing psychotic symptoms in a 14-year-old female with ASD, particularly when integrated with social skill training and environmental support.

Abstract

Abstract Background Autism Spectrum Disorder (ASD), previously referred to as Asperger syndrome, is characterized by deficits in social communication, restricted interests, and rigid behavioral patterns. Although psychotic symptoms are not core features of ASD, adolescents with ASD are at increased risk of developing hallucinations, particularly under psychosocial stress. We present a case report using brexpiprazole in adolescents with ASD with psychotic symptoms. Aims & Objectives This study aims to evaluate the clinical response and tolerability of brexpiprazole in a 14-year-old female vocational high school student with ASD who presented with auditory hallucinations following significant academic and social stressors. Method A single case study design was employed. The participant was a 14-year-old female with ASD who developed daily auditory hallucinations over two months. Brexpiprazole was initiated at 0.5 mg/day and titrated to 1–2 mg/day. Clinical evaluation over six weeks included the frequency of hallucinations, functional performance at school, sleep pattern changes, and adverse effects. Psychosocial interventions included social skills training and family psychoeducation. Results After six weeks of treatment, hallucination frequency decreased by approximately 60%, shifting from daily episodes to 1–2 episodes per week. Anxiety and sleep disturbances improved significantly, and the patient showed better school functioning. No serious adverse effects were observed; only mild transient sedation occurred during the first week. The combination of brexpiprazole and structured psychosocial interventions demonstrated a synergistic effect in reducing psychotic symptoms and anxiety in an adolescent with ASD. Discussion & Conclusions Brexpiprazole appears to be effective and well-tolerated in managing psychotic symptoms in a 14-year-old female with ASD, particularly when integrated with social skill training and environmental support. Larger controlled studies are needed to further establish the efficacy and safety of brexpiprazole in adolescents with ASD presenting with psychosis.

Read PDF

Similar papers

Open access Sep 2026

A Case Report on the Ayurvedic Management of Autism Spectrum Disorder

Neurodevelopmental disorders (NDDs) are a group of heterogeneous conditions arising from impairments in brain development characterized deficits in cognition, language, motor function, behavior, and social communication. Among these, autism spectrum disorder (ASD) is associated with developmental deficits in social com...

Anu Mariam Varghese, Linet Rose, Lekshmi Priya · 0 citations
Open access Oct 2026

Ayurvedic Management of Autism Spectrum Disorder in A Four-YearOld Child: A Case Study

Larger controlled research and long-term follow-up are necessary to confirm the efficacy and create uniform standards for Ayurvedic treatment of neurodevelopmental problems, even though the results were encouraging.

Avinash Sarjeao Survase, Sachin Rameshwar Bhagwat, D. Khawale et al. · 0 citations
Open access Oct 2026

Cannabis-Associated Mania in Young Adult Males: A Case Series

A BSTRACT Cannabis is the most widely used illicit psychoactive substance worldwide. While cannabis-related psychosis is well documented, cannabis-associated mania is a relatively under-recognized clinical entity that poses diagnostic and therapeutic challenges. We describe three young adult males who presented w...

Nikhar Satyapal, Parisha Kelkar, Abhimanyu Sinha et al. · 0 citations
Open access Sep 2026

Comparative Effectiveness of Propranolol Versus Risperidone in Children with Autism Spectrum Disorder

Autism spectrum disorder (ASD) is a neurodevelopmental condition, affecting one in every 68 children in India. It is associated with social communication deficits and restricted, repetitive behaviors, for which pharmacological options are currently limited. Risperidone demonstrates modest efficacy in core domains a...

Sargun Arora, Shivangi Mehta, P. Arun · 0 citations
Case report Open access Sep 2026

Psychotropic Polypharmacy in a 5-Year-Old Boy with a SHANK3 Variant and Complex Mental Health Problems

Background: Dysfunction of the SHANK3 gene has been linked to several neuropsychiatric and neurodevelopmental disorders, such as attention deficit/hyperactivity disorder (ADHD), autism spectrum disorder, and epilepsy. SHANK3 haploinsufficiency is the known etiology of Phelan–McDermid syndrome. Case presentation: This r...

Wolfgang Briegel, Erdmute Kunstmann · 0 citations
Open access 2026

Landau-Kleffner Syndrome Presenting With Autistic Features: A Case Report Highlights the Diagnostic Challenge

Objective: Landau-Kleffner Syndrome (LKS) is a rare pediatric epileptic encephalopathy characterized by the abrupt or gradual loss of previously acquired language abilities and epileptiform EEG abnormalities. The syndrome poses significant diagnostic challenges due to its clinical overlap with autism spectrum disorder...

Şevval Erdem, Fethiye Kılıçaslan, B. Tüysüz et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.